The next wave of drug innovation: GLP-1s, inflammation, and what’s ahead.
Download guide
Rightway co-founder and Chief Medical Officer Ted Feldman, MD, sat down with Michael Belmont, MD, a rheumatologist at NYU Langone Health, at our annual Pharmacy Innovation Forum. The two covered GLP-1s and the anti-inflammatory drugs used for conditions such as rheumatoid arthritis and psoriasis, including what plan sponsors need to know now and what’s ahead. Get five takeaways from their conversation.
